- Home
- OLMA vs MRVI Comparison
OLMA vs MRVI Comparison
Compare OLMA & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- MRVI
- Stock Information
- Founded
- OLMA 2006
- MRVI 2014
- Country
- OLMA United States
- MRVI United States
- Employees
- OLMA N/A
- MRVI N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- OLMA Health Care
- MRVI Health Care
- Exchange
- OLMA Nasdaq
- MRVI Nasdaq
- Market Cap
- OLMA 289.0M
- MRVI 262.9M
- IPO Year
- OLMA 2020
- MRVI 2020
- Fundamental
- Price
- OLMA $4.60
- MRVI $1.98
- Analyst Decision
- OLMA Strong Buy
- MRVI Hold
- Analyst Count
- OLMA 3
- MRVI 9
- Target Price
- OLMA $27.67
- MRVI $6.54
- AVG Volume (30 Days)
- OLMA 848.8K
- MRVI 1.6M
- Earning Date
- OLMA 05-16-2025
- MRVI 05-12-2025
- Dividend Yield
- OLMA N/A
- MRVI N/A
- EPS Growth
- OLMA N/A
- MRVI N/A
- EPS
- OLMA N/A
- MRVI N/A
- Revenue
- OLMA N/A
- MRVI $259,185,000.00
- Revenue This Year
- OLMA N/A
- MRVI N/A
- Revenue Next Year
- OLMA N/A
- MRVI $14.23
- P/E Ratio
- OLMA N/A
- MRVI N/A
- Revenue Growth
- OLMA N/A
- MRVI N/A
- 52 Week Low
- OLMA $2.86
- MRVI $1.67
- 52 Week High
- OLMA $16.62
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- OLMA 49.07
- MRVI 43.17
- Support Level
- OLMA $4.35
- MRVI $1.96
- Resistance Level
- OLMA $5.74
- MRVI $2.16
- Average True Range (ATR)
- OLMA 0.39
- MRVI 0.13
- MACD
- OLMA -0.05
- MRVI 0.04
- Stochastic Oscillator
- OLMA 17.99
- MRVI 47.67
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.